|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 12123 |
FusionGeneSummary for ESYT2_PPP1R3A |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ESYT2_PPP1R3A | Fusion gene ID: 12123 | Hgene | Tgene | Gene symbol | ESYT2 | PPP1R3A | Gene ID | 57488 | 5506 |
| Gene name | extended synaptotagmin 2 | protein phosphatase 1 regulatory subunit 3A | |
| Synonyms | CHR2SYT|E-Syt2|FAM62B | GM|PP1G|PPP1R3 | |
| Cytomap | 7q36.3 | 7q31.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | extended synaptotagmin-2chr2 synaptotagminextended synaptotagmin like protein 2extended synaptotagmin protein 2family with sequence similarity 62 (C2 domain containing), member B | protein phosphatase 1 regulatory subunit 3ARG1glycogen and sarcoplasmic reticulum binding subunit, skeletal muscleglycogen-associated regulatory subunit of protein phosphatase-1protein phosphatase 1 glycogen- associated regulatory subunitprotein phos | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | A0FGR8 | Q16821 | |
| Ensembl transtripts involved in fusion gene | ENST00000251527, ENST00000497111, ENST00000435514, | ENST00000284601, | |
| Fusion gene scores | * DoF score | 10 X 8 X 7=560 | 2 X 1 X 2=4 |
| # samples | 10 | 2 | |
| ** MAII score | log2(10/560*10)=-2.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/4*10)=2.32192809488736 | |
| Context | PubMed: ESYT2 [Title/Abstract] AND PPP1R3A [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | LIHC | TCGA-2Y-A9H8-01A | ESYT2 | chr7 | 158540885 | - | PPP1R3A | chr7 | 113558352 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000251527 | ENST00000284601 | ESYT2 | chr7 | 158540885 | - | PPP1R3A | chr7 | 113558352 | - |
| intron-3CDS | ENST00000497111 | ENST00000284601 | ESYT2 | chr7 | 158540885 | - | PPP1R3A | chr7 | 113558352 | - |
| intron-3CDS | ENST00000435514 | ENST00000284601 | ESYT2 | chr7 | 158540885 | - | PPP1R3A | chr7 | 113558352 | - |
Top |
FusionProtFeatures for ESYT2_PPP1R3A |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ESYT2 | PPP1R3A |
| Seems to act as a glycogen-targeting subunit for PP1.PP1 is essential for cell division, and participates in theregulation of glycogen metabolism, muscle contractility andprotein synthesis. Plays an important role in glycogen synthesisbut is not essential for insulin activation of glycogen synthase(By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 191_370 | 575 | 894 | Domain | SMP-LTD |
| Hgene | ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 372_473 | 575 | 894 | Domain | C2 1 |
| Hgene | ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 125_127 | 575 | 894 | Topological domain | Lumenal |
| Hgene | ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 1_103 | 575 | 894 | Topological domain | Cytoplasmic |
| Hgene | ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 104_124 | 575 | 894 | Transmembrane | Helical |
| Hgene | ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 128_148 | 575 | 894 | Transmembrane | Helical |
| Tgene | >PPP1R3A | chr7:158540885 | chr7:113558352 | ENST00000284601 | - | 0 | 4 | 122_230 | -23 | 1123 | Domain | CBM21 |
| Tgene | >PPP1R3A | chr7:158540885 | chr7:113558352 | ENST00000284601 | - | 0 | 4 | 62_65 | -23 | 1123 | Motif | Note=PP1-binding motif |
| Tgene | >PPP1R3A | chr7:158540885 | chr7:113558352 | ENST00000284601 | - | 0 | 4 | 1078_1098 | -23 | 1123 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | >ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 736_739 | 575 | 894 | Compositional bias | Note=Poly-Ser |
| Hgene | >ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 523_617 | 575 | 894 | Domain | C2 2 |
| Hgene | >ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 788_892 | 575 | 894 | Domain | C2 3 |
| Hgene | >ESYT2 | chr7:158540885 | chr7:113558352 | ENST00000251527 | - | 15 | 22 | 149_921 | 575 | 894 | Topological domain | Cytoplasmic |
Top |
FusionGeneSequence for ESYT2_PPP1R3A |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_ESYT2_ENST00000251527_chr7_158540885_-_PPP1R3A_ENST00000284601_chr7_113558352_-_575aa MTPPSRAEAGVRRSRVPSEGRWRGAEPPGISASTQPASAGRAARHCGAMSGARGEGPEAGAGGAGGRAAPENPGGVLSVELPGLLAQLAR SFALLLPVYALGYLGLSFSWVLLALALLAWCRRSRGLKALRLCRALALLEDEERVVRLGVRACDLPAWVHFPDTERAEWLNKTVKHMWPF ICQFIEKLFRETIEPAVRGANTHLSTFSFTKVDVGQQPLRINGVKVYTENVDKRQIILDLQISFVGNCEIDLEIKRYFCRAGVKSIQIHG TMRVILEPLIGDMPLVGALSIFFLRKPLLEINWTGLTNLLDVPGLNGLSDTIILDIISNYLVLPNRITVPLVSEVQIAQLRFPVPKGVLR IHFIEAQDLQGKDTYLKGLVKGKSDPYGIIRVGNQIFQSRVIKENLSPKWNEVYEALVYEHPGQELEIELFDEDPDKDDFLGSLMIDLIE VEKERLLDEWFTLDEVPKGKLHLRLEWLTLMPNASNLDKVLTDIKADKDQANDGLSSALLILYLDSARNLPSGKKISSNPNPVVQMSVGH |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_ESYT2_ENST00000251527_chr7_158540885_-_PPP1R3A_ENST00000284601_chr7_113558352_-_1725nt ATGACGCCACCGTCCCGGGCGGAGGCGGGCGTGCGGCGGAGCCGCGTCCCCTCAGAGGGGCGCTGGCGCGGGGCTGAGCCGCCCGGGATC AGCGCGAGCACCCAGCCCGCCTCGGCCGGGAGGGCAGCGCGGCACTGCGGGGCGATGAGCGGCGCCCGGGGCGAGGGCCCGGAGGCGGGC GCCGGCGGGGCTGGGGGCCGCGCGGCGCCTGAGAACCCCGGGGGCGTGCTGAGCGTGGAGCTGCCCGGGCTGCTGGCGCAGCTGGCGCGG AGCTTCGCGCTGCTGCTGCCCGTGTACGCGCTGGGCTACCTGGGGCTCAGCTTCAGCTGGGTTCTCCTCGCGCTCGCGCTGCTCGCCTGG TGTCGCCGCAGCCGCGGCCTCAAGGCCCTGCGCCTGTGCCGCGCGCTGGCGCTGCTGGAAGACGAGGAGCGCGTCGTGCGCCTGGGGGTG CGCGCCTGCGACCTGCCCGCCTGGGTTCATTTTCCAGACACTGAAAGAGCAGAATGGCTAAATAAGACTGTAAAACACATGTGGCCTTTC ATTTGCCAATTTATAGAGAAGTTGTTTCGAGAAACTATAGAACCAGCCGTGCGGGGAGCAAACACCCACCTTAGCACCTTTAGTTTCACG AAGGTCGACGTGGGCCAGCAGCCCCTCAGGATCAATGGTGTTAAGGTATACACTGAAAATGTAGACAAAAGGCAAATTATTTTGGACCTT CAGATTAGTTTTGTAGGAAATTGTGAGATTGATTTGGAGATCAAACGATATTTTTGTAGAGCTGGTGTGAAAAGTATCCAGATTCATGGT ACCATGCGGGTGATCCTGGAACCGTTGATTGGAGATATGCCCTTAGTTGGAGCTTTGTCTATCTTCTTCCTTAGGAAACCACTTTTAGAA ATTAACTGGACAGGACTGACGAATCTTCTGGATGTCCCTGGATTGAATGGTTTATCAGATACTATCATTTTGGATATAATATCAAACTAT CTGGTGCTTCCCAATCGAATCACCGTTCCACTTGTCAGTGAAGTTCAAATAGCTCAGTTGCGGTTTCCTGTACCAAAGGGTGTTCTAAGG ATACATTTTATTGAAGCTCAGGATCTTCAGGGGAAAGACACTTACCTTAAGGGACTTGTCAAGGGAAAGTCAGACCCCTATGGAATCATT AGAGTTGGCAACCAAATCTTCCAAAGCAGAGTCATCAAGGAGAACCTCAGTCCAAAGTGGAATGAAGTCTATGAGGCTTTAGTGTATGAA CATCCTGGACAAGAATTAGAGATTGAGCTCTTTGATGAAGACCCAGACAAGGATGACTTTTTAGGAAGTCTTATGATTGACCTCATTGAA GTTGAAAAGGAGCGCCTTTTAGATGAATGGTTCACTCTGGACGAGGTTCCCAAGGGGAAGCTACACTTGAGACTGGAGTGGCTCACGTTA ATGCCAAATGCGTCAAACCTCGACAAGGTGCTAACAGACATCAAAGCTGACAAAGACCAAGCCAACGATGGTCTTTCCTCTGCATTGCTG ATCTTGTACTTGGATTCAGCAAGGAACCTTCCGTCAGGGAAGAAAATAAGCAGCAACCCAAATCCTGTTGTCCAGATGTCAGTTGGGCAC AAGGCCCAGGAGAGCAAGATTCGATACAAAACCAATGAACCTGTGTGGGAGGAAAACTTCACTTTCTTCATTCACAATCCCAAGCGCCAG |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_ESYT2_ENST00000251527_chr7_158540885_-_PPP1R3A_ENST00000284601_chr7_113558352_-_2931nt AGTATCCACCCCGCCCGCTCCCGGTGACGTGCCAGCCCCAGGCCCACGCCGCTCCCGCCCCGCGTGATGACGCCACCGTCCCGGGCGGAG GCGGGCGTGCGGCGGAGCCGCGTCCCCTCAGAGGGGCGCTGGCGCGGGGCTGAGCCGCCCGGGATCAGCGCGAGCACCCAGCCCGCCTCG GCCGGGAGGGCAGCGCGGCACTGCGGGGCGATGAGCGGCGCCCGGGGCGAGGGCCCGGAGGCGGGCGCCGGCGGGGCTGGGGGCCGCGCG GCGCCTGAGAACCCCGGGGGCGTGCTGAGCGTGGAGCTGCCCGGGCTGCTGGCGCAGCTGGCGCGGAGCTTCGCGCTGCTGCTGCCCGTG TACGCGCTGGGCTACCTGGGGCTCAGCTTCAGCTGGGTTCTCCTCGCGCTCGCGCTGCTCGCCTGGTGTCGCCGCAGCCGCGGCCTCAAG GCCCTGCGCCTGTGCCGCGCGCTGGCGCTGCTGGAAGACGAGGAGCGCGTCGTGCGCCTGGGGGTGCGCGCCTGCGACCTGCCCGCCTGG GTTCATTTTCCAGACACTGAAAGAGCAGAATGGCTAAATAAGACTGTAAAACACATGTGGCCTTTCATTTGCCAATTTATAGAGAAGTTG TTTCGAGAAACTATAGAACCAGCCGTGCGGGGAGCAAACACCCACCTTAGCACCTTTAGTTTCACGAAGGTCGACGTGGGCCAGCAGCCC CTCAGGATCAATGGTGTTAAGGTATACACTGAAAATGTAGACAAAAGGCAAATTATTTTGGACCTTCAGATTAGTTTTGTAGGAAATTGT GAGATTGATTTGGAGATCAAACGATATTTTTGTAGAGCTGGTGTGAAAAGTATCCAGATTCATGGTACCATGCGGGTGATCCTGGAACCG TTGATTGGAGATATGCCCTTAGTTGGAGCTTTGTCTATCTTCTTCCTTAGGAAACCACTTTTAGAAATTAACTGGACAGGACTGACGAAT CTTCTGGATGTCCCTGGATTGAATGGTTTATCAGATACTATCATTTTGGATATAATATCAAACTATCTGGTGCTTCCCAATCGAATCACC GTTCCACTTGTCAGTGAAGTTCAAATAGCTCAGTTGCGGTTTCCTGTACCAAAGGGTGTTCTAAGGATACATTTTATTGAAGCTCAGGAT CTTCAGGGGAAAGACACTTACCTTAAGGGACTTGTCAAGGGAAAGTCAGACCCCTATGGAATCATTAGAGTTGGCAACCAAATCTTCCAA AGCAGAGTCATCAAGGAGAACCTCAGTCCAAAGTGGAATGAAGTCTATGAGGCTTTAGTGTATGAACATCCTGGACAAGAATTAGAGATT GAGCTCTTTGATGAAGACCCAGACAAGGATGACTTTTTAGGAAGTCTTATGATTGACCTCATTGAAGTTGAAAAGGAGCGCCTTTTAGAT GAATGGTTCACTCTGGACGAGGTTCCCAAGGGGAAGCTACACTTGAGACTGGAGTGGCTCACGTTAATGCCAAATGCGTCAAACCTCGAC AAGGTGCTAACAGACATCAAAGCTGACAAAGACCAAGCCAACGATGGTCTTTCCTCTGCATTGCTGATCTTGTACTTGGATTCAGCAAGG AACCTTCCGTCAGGGAAGAAAATAAGCAGCAACCCAAATCCTGTTGTCCAGATGTCAGTTGGGCACAAGGCCCAGGAGAGCAAGATTCGA TACAAAACCAATGAACCTGTGTGGGAGGAAAACTTCACTTTCTTCATTCACAATCCCAAGCGCCAGGACCTTGAAGTTGAGGCCTCAGTA TCTCAAATGTCAGCCTCTACTAGTCGTACAGTTCTCTCTTATTTGATATCAGAGAGCCCAATGGAGCCTTCTGAAGTACCTAGTCAGATT AGCAAAGATAATTTTTTAGAAGTTCCTAATTTATCTGACTCTCTTTGTGAAGATGAAGAAGTTACTTTCCAACCTGGTTTCTCCCCTCAA CCAAGTAGACGAGGTTCTGATTCTTCTGAAGACATATACCTGGATACCCCATCTTCAGGTACTAGAAGAGTTTCATTTGCTGATTCCTTT GGATTCAATCTTGTGTCTGTTAAAGAATTTGATTGCTGGGAATTACCGAGTGCTTCAACCACTTTTGACTTAGGGACGGACATTTTCCAC ACAGAAGAATATGTTTTAGCCCCACTGTTTGACTTGCCTTCTTCAAAAGAAGATCTTATGCAACAACTCCAAATACAGAAAGCAATACTG GAGTCAACTGAGTCTCTTCTTGGGTCTACAAGTATCAAGGGTATTATTCGAGTTTTGAATGTTTCTTTTGAGAAGTTAGTATATGTAAGA ATGTCTTTAGATGACTGGCAGACACATTATGACATTTTAGCAGAATATGTTCCTAATTCATGTGATGGTGAAACTGACCAGTTCTCCTTT AAGATTGTATTGGTTCCTCCTTATCAAAAAGATGGCAGTAAAGTTGAGTTTTGTATACGTTATGAAACTTCTGTTGGTACATTTTGGTCA AATAATAATGGCACAAATTATACATTCATTTGTCAAAAGAAAGAACAAGAGCCGGAGCCTGTAAAACCATGGAAAGAAGTTCCTAACAGA CAAATAAAAGGCTGCTTAAAGGTAAAATCAAGTAAAGAAGAATCATCAGTAACATCAGAAGAAAATAACTTTGAGAATCCAAAGAATACA GATACCTATATCCCAACAATCATTTGTTCTCATGAGGACAAGGAAGATTTGGAAGCCAGTAATCGAAATGTAAAAGATGTAAACAGGGAA CATGATGAACATAATGAAAAAGAATTAGAGTTGATGTCAATGCAGACCCTGCAGGACTTGCTCACTGATCTTCATGCACTCCAGGTCACC |
Top |
FusionGenePPI for ESYT2_PPP1R3A |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ESYT2 | CAMKK2, CLN3, SLC2A4, SLC25A17, ECT2, FN1, MAPK15, DERL1, ESYT1, NTRK1, TMEM17, FGD1, PAEP, ATP6AP2, NOP56, ELL2, NCSTN, MPHOSPH8, TUBA1C, IRF3, FAF2, CDH1, CTDSPL, TRIM25, UBQLN1 | PPP1R3A | PLN, BRCA1, PPP1R13B, TP53BP2, CCDC85B, CCDC85C, CDCA2, CNST, C20orf27, PPP1R13L, PPP1R2, KIF18A, MKI67, ERBB2IP, LMTK2, PPP1R9A, PPP1R9B, NUP50, PDRG1, PEAK1, PFDN2, PFDN6, PIH1D1, PPP1CA, PPP1CB, PPP1R7, PPP1R8, PPP1R10, PPP1R11, PPP3CB, PPP1R18, RIF1, URI1, POLR2E, RPAP3, RRP1B, RUVBL2, SCRIB, SHOC2, TOX4, TPRN, WDR82, WDR92, YLPM1, ZFYVE9 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ESYT2_PPP1R3A |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ESYT2_PPP1R3A |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | PPP1R3A | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | HPO;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|